Biocon Biologics, a subsidiary of Biocon, has launched Nepexto, a biosimilar to Enbrel, in Australia. Nepexto is indicated for the treatment of autoimmune conditions like rheumatoid arthritis and ...

Eternal's valuation has now surpassed the market capitalisation of several established names, including Wipro ( ₹2.72 lakh ...